Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
74.38
+1.27 (1.73%)
Jul 24, 2026, 10:40 AM EDT - Market open

Merit Medical Systems Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,5421,5161,3571,2571,1511,075
Revenue Growth
11.10%11.75%7.89%9.24%7.09%11.50%
Gross Profit
751.05738.27643.33583.87519.1485.33
Operating Income
187.84184.72155.69123.9487.5660.92
Net Income
139.34128.49120.3694.4174.5248.45
Earnings Per Share
2.312.132.031.621.290.84
EPS Growth
13.23%4.93%25.31%25.58%53.57%-

Revenue by Segment

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Peripheral Intervention
-579.84532.77502.22439.81405.12
Cardiac Intervention
-448.91368.95358.45343.19320.64
Custom Procedural Solutions
-209.33200.03195.33190.19193.94
OEM
-204.96199.99164.56145.03123.53
Revenue (Total)
1,5421,5161,3571,2571,1511,075

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
488.08446.4203.71587.0458.4167.75
Total Debt
821.56821.57794.67891.36268.75315.03
Net Cash (Debt)
-333.48-375.17-590.96-304.32-210.34-247.28
Net Cash Growth
------
Net Cash Per Share
-5.54-6.21-9.95-5.21-3.65-4.31

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
297.48297.37220.8145.15114.29147.23
Capital Expenditures
-76.66-81.72-35.14-34.29-45.03-27.94
Free Cash Flow
220.82215.66185.66110.8669.26119.29
Free Cash Flow Growth
22.24%16.16%67.47%60.06%-41.94%0.01%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
48.69%48.70%47.43%46.44%45.10%45.16%
Operating Margin
12.18%12.19%11.48%9.86%7.61%5.67%
Pretax Margin
12.09%11.28%11.06%8.91%7.18%5.02%
Profit Margin
9.03%8.48%8.87%7.51%6.47%4.51%
FCF Margin
14.32%14.23%13.69%8.82%6.02%11.10%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
31.5141.3847.6546.8954.7474.17
Forward PE
17.8122.5127.1324.0425.9727.70
P/FCF Ratio
19.7524.2930.6039.6458.4329.54
PS Ratio
2.833.464.193.503.523.28